The post MVRV 30-D Turned Positive: Is Injective Price 20% Jump Just a Start? appeared first on Coinpedia Fintech News
The Injective price isn’t moving quietly anymore. It just ripped 20% intraday, and no, this isn’t one of those random pumps out of nowhere. There’s capital behind it. Real capital. Pineapple Financial (NYSE: PAPL) has accelerated its INJ buying spree, announcing another $2 million acquisition on February 19, 2026, under its ongoing market cash purchase …
